A D - dimer test measures the amount of D - dimer, a protein fragment formed when blood clots break down, in the blood.This test is primarily used to help rule out blood clots in conditions like deep vein thrombosis (DVT) and pulmonary embolism (PE).An elevated D - dimer level suggests the possibility of a blood clot, but further testing is usually required to confirm the diagnosis.

PROTEIN C ACTIVITY IS A BLOOD TEST THAT MEASURES THE FUNCTIONALITY OF PROTEIN C, A NATURAL ANTICOAGULANT IN THE BODY THAT HELPS PREVENT EXCESSIVE BLOOD CLOTTING. LOW PROTEIN C ACTIVITY INCREASES THE RISK OF DEVELOPING BLOOD CLOTS, SUCH AS DEEP VEIN THROMBOSIS (DVT) AND PULMONARY EMBOLISM. THIS TEST IS OFTEN ORDERED WHEN THERE IS A SUSPICION OF AN INCREASED CLOTTING RISK DUE TO FAMILY HISTORY, PREVIOUS BLOOD CLOTS, OR OTHER RISK FACTORS.

THE PTT, OR APTT, IS A LABORATORY TEST USED TO MEASURE HOW LONG IT TAKES BLOOD TO CLOT. IT IS PRIMARILY USED TO EVALUATE THE INTRINSIC PATHWAY OF BLOOD COAGULATION, WHICH INVOLVES SEVERAL CLOTTING FACTORS. AN ABNORMAL PTT RESULT CAN INDICATE A DEFICIENCY OR DYSFUNCTION OF ONE OR MORE OF THESE CLOTTING FACTORS, LEADING TO BLEEDING OR CLOTTING DISORDERS. THE PTT TEST IS COMMONLY USED TO MONITOR ANTICOAGULANT THERAPY, SUCH AS HEPARIN OR LOW-MOLECULAR-WEIGHT HEPARIN, WHICH WORK BY PROLONGING THE CLOTTING TIME.

Fibrinogen is a crucial protein in the blood clotting process.When an injury occurs, platelets gather at the site and release substances that activate fibrinogen.This activation converts fibrinogen into fibrin, a protein that forms a sticky meshwork.This meshwork traps blood cells and platelets, forming a clot that seals the wound and prevents further blood loss.The clotting process is essential for maintaining homeostasis, ensuring that the body can effectively repair injuries and prevent excessive bleeding.

THROMBIN TIME (TT) IS A BLOOD TEST THAT MEASURES HOW LONG IT TAKES FOR BLOOD TO CLOT AFTER ADDING THROMBIN, AN ENZYME CRUCIAL FOR CLOTTING. IT ASSESSES FIBRINOGEN FUNCTION, A KEY CLOTTING PROTEIN. PROLONGED TT CAN INDICATE LOW FIBRINOGEN LEVELS, ABNORMAL FIBRINOGEN, OR THE PRESENCE OF SUBSTANCES INHIBITING CLOTTING, SUCH AS HEPARIN. THIS TEST HELPS DIAGNOSE BLEEDING DISORDERS, MONITOR ANTICOAGULANT THERAPY, AND INVESTIGATE EXCESSIVE CLOTTING OR BLEEDING CONDITIONS

PROTHROMBIN TIME (PT) STUDIES ASSESS YOUR BLOODS CLOTTING ABILITY. IT MEASURES HOW LONG IT TAKES FOR A BLOOD CLOT TO FORM. THIS TEST IS ESSENTIAL FOR DIAGNOSING BLEEDING DISORDERS, MONITORING ANTICOAGULANT THERAPY LIKE WARFARIN, AND EVALUATING LIVER FUNCTION. BY ANALYZING CLOTTING FACTORS, PT HELPS DETERMINE IF YOUR BLOOD CLOTS TOO QUICKLY OR TOO SLOWLY, WHICH CAN INCREASE THE RISK OF BLEEDING OR BLOOD CLOTS.

THE FREE PROTEIN S TEST MEASURES THE AMOUNT OF ACTIVE PROTEIN S IN THE BLOOD. PROTEIN S IS A NATURAL ANTICOAGULANT, A SUBSTANCE THAT HELPS PREVENT EXCESSIVE BLOOD CLOTTING. IT WORKS BY ASSISTING ANOTHER PROTEIN, ACTIVATED PROTEIN C, TO INACTIVATE TWO KEY CLOTTING FACTORS: FACTOR VA AND FACTOR VIIIA. WHEN THERE ISNOT ENOUGH FUNCTIONAL PROTEIN S, THE BLOOD HAS AN INCREASED TENDENCY TO CLOT.

The Lupus Anticoagulant by dRVVT (dilute Russell's viper venom time) test is a coagulation assay used to detect the presence of lupus anticoagulants (LA), which are a type of antiphospholipid antibodies. Despite their name, these antibodies are not typically associated with bleeding disorders or systemic lupus erythematosus and are in fact linked to an increased risk of blood clots (thrombosis). The dRVVT test works by using a diluted venom that directly activates Factor X of the coagulation cascade. A prolonged clotting time in the initial screening phase suggests the presence of an inhibitor. This is followed by a confirmatory test using an excess of phospholipids. If the prolonged clotting time corrects (shortens) in the confirmatory step, it indicates that the inhibitor is phospholipid-dependent, which is a characteristic of lupus anticoagulants.

THIS TEST MEASURES THE FUNCTIONAL ACTIVITY OF ANTITHROMBIN, A PROTEIN THAT HELPS PREVENT BLOOD CLOTS. LOW ANTITHROMBIN ACTIVITY CAN INDICATE AN INCREASED RISK FOR THROMBOSIS (BLOOD CLOTS), SUCH AS DEEP VEIN THROMBOSIS (DVT) OR PULMONARY EMBOLISM (PE). IT CAN BE CAUSED BY A GENETIC DEFICIENCY, LIVER DISEASE, OR OTHER CONDITIONS.